Articles for : GLP-1 drugs
ECONOMY
UPS and Hormel Stocks: Turnaround Potential Amid Investor Worry
Short summary
Despite recent stock drops, UPS and Hormel show signs of recovery with improved efficiency and sales strategies, offering potential for investors.
HEALTH
Amgen's MariTide: A Potential GLP-1 Rival to Eli Lilly's Blockbusters
Short summary
Amgen’s MariTide, a monthly injectable GLP-1 drug, could challenge Eli Lilly’s dominance, offering a convenient alternative for weight loss and diabetes.